Business
Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study
Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that Emmanuela Derisbrun, APRN, FNP-C, has transitioned from subcontractor to employed provider. This move supports rising patient volume and the launch of Adia Med's IRB-approved autism spectrum disorder regenerative study.Emmanuela Derisbrun, APRN, FNP-CTo view an enhanced version of this graphic, please.
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that Emmanuela Derisbrun, APRN, FNP-C, has transitioned from subcontractor to employed provider. This move supports rising patient volume and the launch of Adia Med's IRB-approved autism spectrum disorder regenerative study.","length":420,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":734,"url":"https://media.zenfs.com/en/newsfile_64/20f035a15f194bf44619cbb6cbb2cbcc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/W9y1cKVIvPxfheF8FX.gAA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEyODE7Y2Y9d2VicA--/https://media.zenfs.com/en/newsfile_64/20f035a15f194bf44619cbb6cbb2cbcc","width":550,"height":734}},"href":"https://images.newsfilecorp.com/files/10520/280518_screenshot_emmy_np_photo_550.jpg","hrefExternal":true},{"type":"text","content":"Emmanuela Derisbrun, APRN, FNP-CTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/280518_screenshot_emmy_np_photo_550.jpg","length":176,"tagName":"p","attribs":{}},{"type":"text","content":"A board-certified Family Nurse Practitioner with extensive outpatient specialty experience, Emmanuela served as a subcontractor at Adia Med for the past year, where she has already administered stem cell treatments and therapeutic plasma exchange (TPE) while delivering evidence-based, patient-centered care under strict clinical and safety protocols.","length":351,"tagName":"p"},{"type":"text","content":"Her background includes IV vitamin therapies and management of hormone replacement, thyroid disorders, hypertension, diabetes, sickle cell disease, post-COVID conditions, and chronic pain. She collaborates in multidisciplinary teams to ensure high-quality care, accurate documentation, and positive patient outcomes.","length":316,"tagName":"p"},{"type":"text","content":"Committed to education, informed consent, and safety, Emmanuela is expanding her work in investigational therapies, including the autism IRB study, as part of her professional growth in regenerative medicine.","length":208,"tagName":"p"},{"type":"text","content":""Emmanuela has been ...